Meetings and publications | |
>> VHPB meetings |
Viral Hepatitis Prevention Board Meeting
Veyrier-Du-Lac, France, November 18-19, 2004
- Meeting Programme -
Prevention and control of viral hepatitis in France: Lessons learnt and the way forward
Thursday, November 18, 2004
Session 1: Opening and objectives
Chair: Nicole Guérin and Nedret Emiroglu
09.00 - 09.30
Session 2: The health-care system in France
Chair: Nicole Guérin and Nedret Emiroglu
09.30 - 09.55
Organisation, preventive health-care system, and financement 418 Kb (.pdf)
Martine Le Quellec-Nathan, France
09.55 - 10.20
French national programme for viral hepatitis prevention and control 353 Kb (.pdf)
Anne-Marie Jullien-Depradeux, France
10.20 - 10.40 Coffee break
Chair: Françoise Roudot-Thoraval and Johannes Hallauer
10.40 - 11.05
Research on viral hepatitis: organisation and funding 676 Kb (.pdf)
Jean-Michel Pawlotsky, Créteil, France
11.05 - 11.30
HBV immunisation policies 159 Kb (.pdf)
Nicole Guérin, Antony, France
Session 3: Surveillance systems for viral hepatitis
Chair: Françoise Roudot-Thoraval and Johannes Hallauer
11.30 - 11.55
Overview of HAV, HBV, and HCV surveillance 237 Kb (.pdf)
Elisabeth Delarocque, France
11.55 - 12.20
Nosocomial HCV infections 184 Kb (.pdf)
Anne Carbonne, Paris, France
12.20 - 12.45
Surveillance of adverse events following immunisation 380 Kb (.pdf)
Alexis Jacquet, France
12.45 - 14.00 Lunch
Session 4: Epidemiology of viral hepatitis in France
Chair: Daniel Lévy-Bruhl and Harold Margolis
14.00 - 14.30
Epidemiology of hepatitis A (including serological data in military) 852 Kb (.pdf)
Elisabeth Nicand, Val-de-Grâce, France
14.30 - 15.00
Epidemiology of hepatitis B 530 Kb (.pdf)
Fabien Zoulim, Lyon, France
15.00 - 15.30
Epidemiology of hepatitis C 427 Kb (.pdf)
Françoise Roudot-Thoraval, Paris, France
15.30 - 15.50 Coffee break
15.50 - 16.20
Regional registries (HBV and HCV, Côte d’Or and Doubs)
Patrick Hillon, Dijon, France
16.20 - 16.50
Prediction of hepatitis C burden due to cirrhosis and cancer 194 Kb (.pdf)
Sylvie Burban, France
Friday, November 19, 2004
Session 5: Prevention and control of viral hepatitis in France
Chair: Patrick Marcellin and Peter Grob
09.00 - 09.25
Prevention and residual risk of HCV, HIV, and HBV infection following blood transfusion 514 Kb (.pdf)
Syria Laperche, Paris, France
09.25 - 09.50
Injecting drug users and HCV infection: prevention strategies and results 493 Kb (.pdf)
Damien Lucidarme, France
09.50 - 10.15
Preventive measures for prisoners 398 Kb (.pdf)
Claire Wartelle, Aix-en-Provence, France
10.15 - 10.35 Coffee break
Session 6: Evaluation of viral hepatitis prevention and control measures - prospects
Chair: Daniel Dhumeaux and Daniel Lavanchy
10.35 - 11.00
French national programme for prevention and control of viral hepatitis: preliminary results 139 Kb (.pdf)
Patrick Marcellin, Paris, France
11.00 - 11.25
Impact of hepatitis B vaccine safety issues on vaccination strategies and their implementation in France 187 Kb (.pdf)
Daniel Lévy-Bruhl, Saint-Maurice, France
11.25 - 11.50
HBV and HCV infection in health-care workers 429 Kb (.pdf)
Yazdan Yazdanpanah, France
11.50 - 12.15
What still needs to be done
Jean-Claude Desenclos, Saint-Maurice, France
12.15 - 14.15 Lunch
Session 7: Conclusions
Chair: Jean-Claude Desenclos and André Meheus
14.15 - 15.30
Presentation of the VHPB meeting conclusions, including discussion 89 Kb (.pdf) Updated version since 12/12/04
Guido François, VHPB
15.30 Close of the meeting